Beyond market trends, investors looking for superior returns explore the world of stock picking. The right selections can be a powerful driver for wealth accumulation.
As of close of business last night, Lyra Therapeutics Inc’s stock clocked out at $0.10, up 4.03% from its previous closing price of $0.09. In other words, the price has increased by $4.03 from its previous closing price. On the day, 1.22 million shares were traded.
Ratios:
To gain a deeper understanding of LYRA’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 2.96 and its Current Ratio is at 2.96. In the meantime, Its Debt-to-Equity ratio is 8.62 whereas as Long-Term Debt/Eq ratio is at 7.52.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, Jefferies on May 07, 2024, Downgraded its rating to Hold and sets its target price to $0.50 from $10 previously.
On May 07, 2024, H.C. Wainwright Downgraded its rating to Neutral which previously was Buy and also lowered its target price recommendation from $12 to $2.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Apr 25 ’25 when Waksal Harlan bought 145,370 shares for $0.10 per share.
Palasis Maria bought 39,567 shares of LYRA for $3,545 on Apr 09 ’25.
Valuation Measures:
For the stock, the TTM Price-to-Sale (P/S) ratio is 5.47 while its Price-to-Book (P/B) ratio in mrq is 1.67.
Stock Price History:
Over the past 52 weeks, LYRA has reached a high of $0.42, while it has fallen to a 52-week low of $0.08. The 50-Day Moving Average of the stock is -26.06%, while the 200-Day Moving Average is calculated to be -53.63%.
Shares Statistics:
A total of 65.88M shares are outstanding, with a floating share count of 55.18M. Insiders hold about 16.73% of the company’s shares, while institutions hold 37.23% stake in the company.
